RxDoctor Payments Data

Garieann Fish, DO

Gastroenterology · Bristol, TNNPI 1821204751

Payments from drug & device makers

$4,101in general payments, 2019–2025

Across 274 payments — averaging $14.97 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$1K
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$853
  • Johnson & Johnson$305
  • Takeda Pharmaceuticals U.S.A., Inc.$235
  • Aimmune Therapeutics, Inc.$224
  • Pfizer$187
  • plus $1K from 21 others

What the payments were for

  • Food & beverage$4,101100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$4,101 in reported general payments places this provider in the 50th percentile of 336 gastroenterology providers in Tennessee.

See all gastroenterology providers in Tennessee

Medicare billing

Part B allowed, 2024
$270,892
Medicare patients
526
Services billed
4,060

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
LinzessLinaclotide148$104,297
XifaxanRifaximin41$81,512
MotegrityPrucalopride Succinate28$14,277
Mesalamine35$6,683
Budesonide EcBudesonide30$6,466
TrulancePlecanatide11$6,169
Sucralfate37$5,639
Omeprazole409$5,601
Lubiprostone39$4,877
Famotidine426$4,359
Colestipol Hcl61$4,211
Dicyclomine Hcl162$3,850
Ursodiol23$3,842
Pantoprazole Sodium351$3,687
Esomeprazole Magnesium98$3,188

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
AbbVieLinzess$1,272$104,297148 claims
Salix Pharmaceuticals, A Division Of Bausch Health US, LLCXifaxan, Trulance$853$87,68052 claims
Takeda Pharmaceuticals U.S.A., Inc.Motegrity$235$14,27728 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 336 gastroenterology providers in Tennessee.

Other gastroenterology in Bristol

See the full list for Tennessee

Where these figures come from

Is this you, or does something look wrong? →